In our study, we found a stronger negative correlation between sFlt-1 and PlGF levels in the CHD group than in the control group, suggesting that the observed decrease in PlGF is linked to dysregulated placental production of sFlt-1 in CHD patients, similar to what occurs in preeclampsia. The gene discussed is PGF; the disease is coronary artery disorder.